Literature DB >> 19685057

The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.

Bedriye Mermerci Başkan1, Yasemin Pekin Doğan, Filiz Sivas, Hatice Bodur, Kürşat Ozoran.   

Abstract

In this study, the relation between osteoporosis and vitamin D and the disease activity in patients with ankylosing spondylitis (AS) was investigated. A hundred patients with AS and 58 healthy individuals were included in the study. In addition to the routine blood and urine tests, serum 25-(OH)D3, parathormone (PTH), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), total calcium, ionized calcium, and phosphorous levels of all participants were also measured. Bone mineral density (BMD) measurements were performed at the anterior-posterior and lateral lumbar and femur regions. Anterior-posterior and lateral thoracic and lumbosacral radiography was performed on all participants. The disease activity was evaluated by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), functional status by Bath Ankylosing Spondylitis Functional Index (BASFI), and mobility by Bath Ankylosing Spondylitis Metrology Index (BASMI). In the patient group, BMD values obtained from the lateral lumbar and femur regions and serum vitamin D levels were lower than the control group. A negative relation was determined between the lateral lumbar BMD values and ESR, CRP, and BASDAI scores of patients with AS. The ESR, CRP levels, and BASMI scores of the AS patients with osteoporosis were significantly higher, when compared to patients without osteoporosis. The negative correlation between serum 25-(OH)D3 level and ESR, CRP levels did not reach a statistically significant level in patients with AS; the positive correlation between PTH levels and ESR, and the negative correlation between CRP and BASDAI also did not reach a statistically significant level. Vitamin D deficiency in AS may indirectly lead to osteoporosis by causing an increase in the inflammatory activity. The present authors believe that it would be beneficial to monitorize vitamin D levels together with BMD measurements in order to determine the patients under osteoporosis risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19685057     DOI: 10.1007/s00296-009-0975-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  39 in total

1.  Osteoporosis in early ankylosing spondylitis: a primary pathological event?

Authors:  R Will; R Palmer; A K Bhalla; F Ring; A Calin
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

2.  Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis.

Authors:  U Lange; O Jung; J Teichmann; G Neeck
Journal:  Osteoporos Int       Date:  2001-12       Impact factor: 4.507

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.

Authors:  Helmut Franck; Thomas Meurer; Lorenz Christian Hofbauer
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

5.  The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis.

Authors:  Erdal Gilgil; Cahit Kaçar; Tiraje Tuncer; Bülent Bütün
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

6.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

Review 7.  Osteoporosis and ankylosing spondylitis.

Authors:  Abdellah El Maghraoui
Journal:  Joint Bone Spine       Date:  2004-07       Impact factor: 4.929

8.  Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo.

Authors:  L Nguyen; F E Dewhirst; P V Hauschka; P Stashenko
Journal:  Lymphokine Cytokine Res       Date:  1991-04

9.  Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography.

Authors:  J P Devogelaer; B Maldague; J Malghem; C Nagant de Deuxchaisnes
Journal:  Arthritis Rheum       Date:  1992-09

10.  Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis.

Authors:  T Masud; S Langley; P Wiltshire; D V Doyle; T D Spector
Journal:  BMJ       Date:  1993-07-17
View more
  25 in total

Review 1.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

Review 2.  T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)₂ vitamin D.

Authors:  Amolak S Bansal; Frances Henriquez; Nazira Sumar; Sanjeev Patel
Journal:  Rheumatol Int       Date:  2011-09-15       Impact factor: 2.631

3.  Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis.

Authors:  Mehmet Ali Ulu; Remzi Çevik; Banu Dilek
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

4.  Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.

Authors:  Simeon Grazio; Zvonko Kusić; Selma Cvijetić; Frane Grubišić; Antonija Balenović; Tomislav Nemčić; Valentina Matijević-Mikelić; Marija Punda; Joachim Sieper
Journal:  Rheumatol Int       Date:  2011-08-20       Impact factor: 2.631

5.  Bone mass in axial spondyloarthritis: A literature review.

Authors:  Erkan Kilic; Salih Ozgocmen
Journal:  World J Orthop       Date:  2015-03-18

6.  Study of bone mineral density in patients with ankylosing spondylitis.

Authors:  Hatinder Jeet Singh; Kaur Nimarpreet; Sibadatta Das; Ashok Kumar; Shesh Prakash
Journal:  J Clin Diagn Res       Date:  2013-12-15

7.  The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study.

Authors:  E Klingberg; G Oleröd; O Hammarsten; H Forsblad-d'Elia
Journal:  Osteoporos Int       Date:  2016-01-25       Impact factor: 4.507

Review 8.  High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.

Authors:  M A C van der Weijden; T A M Claushuis; T Nazari; W F Lems; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Clin Rheumatol       Date:  2012-06-16       Impact factor: 2.980

9.  The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.

Authors:  S Arends; A Spoorenberg; G A W Bruyn; P M Houtman; M K Leijsma; C G M Kallenberg; E Brouwer; E van der Veer
Journal:  Osteoporos Int       Date:  2010-07-06       Impact factor: 4.507

10.  Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment.

Authors:  Eva Klingberg; Mattias Lorentzon; Dan Mellström; Mats Geijer; Jan Göthlin; Elisabet Hilme; Martin Hedberg; Hans Carlsten; Helena Forsblad-d'Elia
Journal:  Arthritis Res Ther       Date:  2012-05-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.